Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 35.07 billion as of October 29, 2025. Its market cap has increased by 13.47% in one year.

Market Cap

35.07B

Enterprise Value

32.06B

Revenue

6.50B

Ranking

n/a

PE Ratio

1.44

Stock Price

16.05

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 35.07B, an increase of 1,560.72%. That is a compound annual growth rate of 33.07%.

Market Cap History

Date	Market Cap	% Change
Oct 28, 2025	35.07B	66.26%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	269.73B
Hansoh Pharmaceutical Group Company	210.92B
JD Health International	201.53B
WuXi Biologics	151.53B
Innovent Biologics	144.96B
Sino Biopharmaceutical	126.75B
Akeso	106.48B
Sichuan Kelun-Biotech Biopharmaceutical	100.18B

Market Cap Rankings